A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19. The study, which will involve 1,000 patients from across the country, will include at least 40 Canadian hospitals.
The experimental treatment involves injecting antibody-rich plasma from patients who have recovered from the virus into those who are still infected. This approach has only been tried in small trials in China, Singapore, South Korea and the U.S. It is part of a global race to find a treatment for the disease, with researchers also focusing on antivirals and medications used to treat malaria.
Donation centres across Canada will extract plasma from recovered patients and test that it has a certain minimum number of antibodies to be considered useful as an immunotherapy. Known as convalescent plasma, the material will then be frozen, sent to participating hospitals and infused into a critical patient to see if it can help treat their illness. In the early stages of infection, the body doesn’t produce the antibodies needed to fight off the novel coronavirus, according to Dr. Donald Arnold, a hematologist at McMaster University who is leading the trial.
More here: theglobeandmail.com/canada/...
Observation points from me: the timing of this potential treatment will be crucial. Other articles have said that patients need ventilation as a result of the cytokine storm that damages the lungs (not the virus infection itself). This then leaves the patient with dangerously low oxygen levels which in turn can lead to kidney and heart failure. It's hard to know how antibodies will help at this point so the immunoglobulins will probably need to be give earlier in the infection to stop it progressing to this stage. The difficulty here is that vast majority of patients do not progress to needing ventilation.
Stay home, stay safe
Jackie